NICE publishes new guidance on chronic pain management
Guidelines recommend exercise programmes and psychological therapies rather than commonly used drugs
Read More
Tag: guidance
Tecentriq hit with draft NICE rejection
The UK watchdog says that the “long-term benefit on overall survival is uncertain”.
Read More
NICE recommends gammaCore for cluster headaches
The portable technology aims to modify pain signals by stimulating the vagus nerve through the skin of the neck.
Read More
NICE explores extending use of real world data to inform guidance
A consultation has begun on NICE’s Statement of Intent.
Read More
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
- Fabentech secures French approval for Ricimed antidote
